| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.06 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |